Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

HIV/AIDS

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
 

Chronic Hepatitis C Virus (HCV) Infection: Treatment Considerations

for Veterans and the Public

Chronic Hepatitis C Virus (HCV) Infection: Treatment Considerations

Contents

Full PDF Version

Introduction

This revision (October 18, 2017) incorporates updates to treatment regimens for chronic hepatitis C virus (HCV) infection, genotypes 1-4, including re-treatment of patients who previously failed direct-acting antiviral therapy. New and updated sections include:

The Panel continues to recommend:

  • HIV/HCV-coinfected patientsPDF icon receive the same HCV antiviral regimens as HCV-monoinfected patients unless ledipasvir/sofosbuvir is being considered, in which case a 12-week regimen should be used (instead of an 8-week regimen).
  • HBV testing and monitoring prior to starting HCV DAA. Details can be found in Appendix DPDF icon.